Retrospective study to describe prevalence of hyperkalemia in Russian population based on large laboratory network (HEKATE)

Study identifier:D1843R00280

ClinicalTrials.gov identifier:NCT03657875

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Retrospective study to describe prevalence of hyperkalemia in Russian population based on large laboratory network

Medical condition

Hyperkalemia Elevated plasma K+ cardiovascular disease (CVD)

Phase

N/A

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

53940

Study type

Observational

Age

N/A

Date

Study Start Date: 15 Sept 2017

Primary Completion Date: 15 Sept 2017

Study Completion Date: 15 Sept 2017

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Sept 2018 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions

Documents available

Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Clinical Study Information Center

1-877-240-9479

[email protected]